Skip to main content
. 1998 Aug;113(2):258–264. doi: 10.1046/j.1365-2249.1998.00632.x

Fig. 2.

Fig. 2

Glomerular iNOS/β-actin and TGF-β1/β-actin mRNA ratio changes. (a) A 15.1% reduction of mean glomerular iNOS:β-actin mRNA ratio in aminoguanidine-treated NZB/W F1 mice. (b) A 63.6% reduction of mean glomerular TGF-β1:β-actin mRNA ratio in aminoguanidine-treated mice compared with control mice. CON, Control NZB/W F1 mice; AG, aminoguanidine-treated mice. *P < 0.05; **P < 0.01.